Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma.

about

Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

P2860

Q38922319-9E45777E-4619-43A8-8045-B86FE92D8214

P2860

Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma.

Item

http://www.wikidata.org/entity/Q44718464

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@en

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@nl

type

Item

label

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@en

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@nl

prefLabel

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@en

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@nl

P1476

Prognostic Value of Hepatocyte ...... Perihilar Cholangiocarcinoma.

@en

P2093

Gen Sugawara

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Watanabe

http://www.w3.org/2001/XMLSchema#string

Masato Nagino

http://www.w3.org/2001/XMLSchema#string

Takashi Mizuno

http://www.w3.org/2001/XMLSchema#string

Tomoki Ebata

http://www.w3.org/2001/XMLSchema#string

Toshio Kokuryo

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Igami

http://www.w3.org/2001/XMLSchema#string

Yoshie Shimoyama

http://www.w3.org/2001/XMLSchema#string

Yukihiro Yokoyama

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-talk between the proto-oncogenes Met and Ron

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Identification of the ron gene product as the receptor for the human macrophage stimulating protein

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness

Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor

The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein

From concept to reality: the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer.

P2888

s10434-014-4170-z

P304

2235-2242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-014-4170-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044305775

http://www.w3.org/2001/XMLSchema#string

P698

25586241

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma.

about

P2860

P2860

Prognostic Value of Hepatocyte Growth Factor Receptor Expression in Patients with Perihilar Cholangiocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921